Clinicopathological features and outcome of type 3 gastric neuroendocrine tumours
Sign Up to like & getrecommendations! Published in 2018 at "British Journal of Surgery"
DOI: 10.1002/bjs.10901
Abstract: With the widespread use of endoscopy, small and low‐grade type 3 gastric neuroendocrine tumours (NETs) are increasingly being detected. The clinicopathological features, biological behaviour and appropriate treatment strategy for these NETs remain unclear. read more here.
Keywords: features outcome; gastric neuroendocrine; neuroendocrine tumours; type gastric ... See more keywords
Phase I study of adjuvant chemotherapy with nab‐paclitaxel and S‐1 for stage III Lauren's diffuse‐type gastric cancer after D2 resection (NORDICA study)
Sign Up to like & getrecommendations! Published in 2022 at "Cancer Medicine"
DOI: 10.1002/cam4.4966
Abstract: The prognosis of diffuse‐type gastric cancer (DGC) is poorer than that of intestinal type, but S‐1 is a potential treatment option in DGC. This study explored the maximal tolerated dose (MTD) and the recommended dose… read more here.
Keywords: type gastric; diffuse type; gastric cancer; phase study ... See more keywords
A non-randomized confirmatory trial of an expanded indication for endoscopic submucosal dissection for intestinal-type gastric cancer (cT1a): the Japan Clinical Oncology Group study (JCOG0607)
Sign Up to like & getrecommendations! Published in 2017 at "Gastric Cancer"
DOI: 10.1007/s10120-017-0704-y
Abstract: BackgroundEndoscopic resection has been limited to intestinal-type gastric cancer (cT1a) with a low risk of lymph node metastasis (T1a ≤2 cm, without ulcers). This single-arm confirmatory trial evaluated the efficacy and safety of endoscopic submucosal dissection… read more here.
Keywords: gastric cancer; intestinal type; type gastric; oncology ... See more keywords
Cancer gene profiling explores the possible precision medicine for diffuse-type gastric adenocarcinoma
Sign Up to like & getrecommendations! Published in 2019 at "Medical Oncology"
DOI: 10.1007/s12032-019-1327-4
Abstract: Diffuse type gastric cancer (DGC), a pathological subtype, is one of the most common malignant solid tumors, and mortality of this tumor is not negligible, especially in early-onset cancer patients. In fact, affirmative personalized treatments… read more here.
Keywords: medicine; diffuse type; dgc; cancer ... See more keywords
Radiotherapy benefited the survival of patients with intestinal-type gastric adenocarcinoma: a SEER population-based study
Sign Up to like & getrecommendations! Published in 2020 at "Clinical and Translational Oncology"
DOI: 10.1007/s12094-020-02408-5
Abstract: Background Currently, the role of adjuvant radiotherapy (RT) in the treatment of patients with intestinal-type gastric adenocarcinoma (IGA) has not been well established. This study aimed to elucidate the survival impact of RT on such… read more here.
Keywords: patients intestinal; gastric adenocarcinoma; study; survival patients ... See more keywords
Netazepide Inhibits Expression of Pappalysin 2 in Type 1 Gastric Neuroendocrine Tumors
Sign Up to like & getrecommendations! Published in 2020 at "Cellular and Molecular Gastroenterology and Hepatology"
DOI: 10.1016/j.jcmgh.2020.01.010
Abstract: Background & Aims In patients with autoimmune atrophic gastritis and achlorhydria, hypergastrinemia is associated with the development of type 1 gastric neuroendocrine tumors (gNETs). Twelve months of treatment with netazepide (YF476), an antagonist of the… read more here.
Keywords: type gnets; neuroendocrine tumors; expression; gastric neuroendocrine ... See more keywords
Transferrin receptor 1 promotes the fibroblast growth factor receptor-mediated oncogenic potential of diffused-type gastric cancer
Sign Up to like & getrecommendations! Published in 2022 at "Oncogene"
DOI: 10.1038/s41388-022-02270-5
Abstract: Diffuse-type gastric cancer (DGC) is a highly invasive subtype of gastric adenocarcinoma that frequently exhibits scattered peritoneal metastasis. Previous studies have shown that the genes of receptor tyrosine kinases (RTKs), such as fibroblast growth factor… read more here.
Keywords: dgc; type gastric; fibroblast growth; gastric cancer ... See more keywords
Diverse Expression of IL-32 in Diffuse and Intestinal Types of Gastric Cancer
Sign Up to like & getrecommendations! Published in 2018 at "Gastroenterology Research and Practice"
DOI: 10.1155/2018/6578273
Abstract: Introduction Gastric cancer (GC) represents one of the most common cancers worldwide, frequently diagnosed at advanced stages with poor prognosis, indicating on need for new diagnostic and prognostic markers. The aim of the study was… read more here.
Keywords: gastric cancer; diffuse type; expression; diffuse intestinal ... See more keywords
Distinct Chemopreventive Effects of Aspirin in Diffuse and Intestinal-Type Gastric Cancer
Sign Up to like & getrecommendations! Published in 2018 at "Cancer Prevention Research"
DOI: 10.1158/1940-6207.capr-17-0276
Abstract: Introduction: Although aspirin/NSAIDs may have potential preventive effects on several cancers, it remains unclear on gastric cancer. The purpose of this study is to compare the risk of developing gastric cancer and the histologic changes… read more here.
Keywords: cancer; intestinal type; type gastric; gastric cancer ... See more keywords
A Prospective and Retrospective Clinical Controlled Observation of Chinese Herbal Decoction (SMLJ01) for Type 1 Gastric Neuroendocrine Tumors
Sign Up to like & getrecommendations! Published in 2020 at "Integrative Cancer Therapies"
DOI: 10.1177/1534735420958488
Abstract: Introduction: Type 1 gastric neuroendocrine tumors (g-NETs) have a good prognosis but a high recurrence rate. Aim: To observe the clinical efficacy of the treatment of type 1 g-NETs with the Chinese herbal decoction SMLJ01.… read more here.
Keywords: recurrence; smlj01; control; treatment ... See more keywords
Response and relapse rates after treatment with long-acting somatostatin analogs in multifocal or recurrent type-1 gastric carcinoids: A systematic review and meta-analysis
Sign Up to like & getrecommendations! Published in 2020 at "United European Gastroenterology Journal"
DOI: 10.1177/2050640619890465
Abstract: Background Type-1 gastric neuroendocrine tumors represent a recurring disease and long-acting somatostatin analogs can inhibit both gastrin release and endocrine cell proliferation. The efficacy and timing of this treatment are still unclear. We performed a… read more here.
Keywords: somatostatin analogs; response; gastric neuroendocrine; somatostatin ... See more keywords